STOCK TITAN

[144] Artivion, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Artivion, Inc. (AORT) filed a Form 144 reporting a proposed sale of common stock. The filing shows 10,802 shares intended for sale on 08/12/2025 through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $471,752.51. The issuer's outstanding shares are listed as 47,183,658.

The securities were acquired on 08/12/2025 through a stock option exercise from the issuer and paid in cash. The filer reports "Nothing to Report" for securities sold during the past three months. The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.

Artivion, Inc. (AORT) ha presentato un Form 144 che segnala una proposta di vendita di azioni ordinarie. Il documento indica 10,802 azioni destinate alla vendita il 08/12/2025 tramite Morgan Stanley Smith Barney LLC sul NYSE con un valore di mercato aggregato di $471,752.51. Le azioni in circolazione dell'emittente sono riportate come 47,183,658.

I titoli sono stati acquistati il 08/12/2025 tramite un esercizio di stock option dall'emittente e pagati in contanti. Il dichiarante segnala "Niente da segnalare" per titoli venduti negli ultimi tre mesi. L'avviso include la rappresentazione standard che il venditore non è in possesso di informazioni negative materiali non divulgate sull'emittente.

Artivion, Inc. (AORT) presentó un Form 144 informando una propuesta de venta de acciones ordinarias. La presentación muestra 10,802 acciones previstas para su venta el 08/12/2025 a través de Morgan Stanley Smith Barney LLC en la NYSE con un valor de mercado agregado de $471,752.51. Las acciones en circulación del emisor se indican como 47,183,658.

Los valores fueron adquiridos el 08/12/2025 mediante un ejercicio de stock options del emisor y pagados en efectivo. El declarante informa "Nada que informar" por valores vendidos en los últimos tres meses. El aviso incluye la declaración estándar de que el vendedor no posee información material adversa no divulgada sobre el emisor.

Artivion, Inc. (AORT)은 제안된 보통주 매각을 보고한 Form 144를 제출했습니다. 제출서에는 10,802주가 08/12/2025Morgan Stanley Smith Barney LLC를 통해 NYSE에서 매각될 예정이며 총 시가가 $471,752.51로 표시되어 있습니다. 발행회사의 유통 주식수는 47,183,658주로 기재되어 있습니다.

해당 증권은 발행회사로부터의 스톡옵션 행사를 통해 08/12/2025에 취득되었으며 현금으로 지급되었습니다. 신고인은 지난 3개월 동안 매각된 증권에 대해 "보고할 사항 없음"이라고 보고했습니다. 통지서에는 매도인이 발행회사에 관한 미공개 중대한 불리한 정보를 보유하고 있지 않다는 표준 진술이 포함되어 있습니다.

Artivion, Inc. (AORT) a déposé un Form 144 signalant une proposition de vente d'actions ordinaires. Le dépôt indique 10,802 actions destinées à la vente le 08/12/2025 par l'intermédiaire de Morgan Stanley Smith Barney LLC sur le NYSE pour une valeur de marché globale de $471,752.51. Le nombre d'actions en circulation de l'émetteur est indiqué comme 47,183,658.

Les titres ont été acquis le 08/12/2025 par exercice d'options sur actions auprès de l'émetteur et réglés en espèces. Le déclarant indique "Rien à déclarer" pour les titres vendus au cours des trois derniers mois. L'avis comprend la déclaration standard selon laquelle le vendeur ne détient pas d'informations défavorables importantes non divulguées concernant l'émetteur.

Artivion, Inc. (AORT) hat ein Form 144 eingereicht, in dem ein geplanter Verkauf von Stammaktien gemeldet wird. Die Einreichung weist 10,802 zum Verkauf vorgesehene Aktien am 08/12/2025 über Morgan Stanley Smith Barney LLC an der NYSE mit einem aggregierten Marktwert von $471,752.51 aus. Die ausstehenden Aktien des Emittenten sind mit 47,183,658 angegeben.

Die Wertpapiere wurden am 08/12/2025 durch Ausübung einer Aktienoption vom Emittenten erworben und in Bargeld bezahlt. Der Einreicher meldet "Nichts zu melden" für in den letzten drei Monaten veräußerte Wertpapiere. Die Mitteilung enthält die übliche Zusicherung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten besitzt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A routine Form 144 for 10,802 shares valued at $471,752; size and disclosure suggest limited investor impact.

The filing documents a proposed sale of 10,802 common shares on 08/12/2025 via Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $471,752.51 and 47,183,658 shares outstanding. The shares were acquired the same day by stock option exercise and paid in cash. No prior sales are reported for the past three months. From a trading-impact perspective, the transaction is modest relative to typical market volumes and the filing meets Rule 144 disclosure conventions.

TL;DR: Documentation aligns with Rule 144 mechanics; includes seller's certification on material nonpublic information.

The Form 144 lists the broker, class of security, acquisition method (stock option exercise), payment type (cash), and that there were no sales in the preceding three months. The filing also contains the signature representation that the seller does not possess undisclosed material adverse information. These elements indicate procedural compliance with Rule 144 disclosure requirements; there is no evidence in the filing of aggregated sales or additional beneficiaries requiring disclosure.

Artivion, Inc. (AORT) ha presentato un Form 144 che segnala una proposta di vendita di azioni ordinarie. Il documento indica 10,802 azioni destinate alla vendita il 08/12/2025 tramite Morgan Stanley Smith Barney LLC sul NYSE con un valore di mercato aggregato di $471,752.51. Le azioni in circolazione dell'emittente sono riportate come 47,183,658.

I titoli sono stati acquistati il 08/12/2025 tramite un esercizio di stock option dall'emittente e pagati in contanti. Il dichiarante segnala "Niente da segnalare" per titoli venduti negli ultimi tre mesi. L'avviso include la rappresentazione standard che il venditore non è in possesso di informazioni negative materiali non divulgate sull'emittente.

Artivion, Inc. (AORT) presentó un Form 144 informando una propuesta de venta de acciones ordinarias. La presentación muestra 10,802 acciones previstas para su venta el 08/12/2025 a través de Morgan Stanley Smith Barney LLC en la NYSE con un valor de mercado agregado de $471,752.51. Las acciones en circulación del emisor se indican como 47,183,658.

Los valores fueron adquiridos el 08/12/2025 mediante un ejercicio de stock options del emisor y pagados en efectivo. El declarante informa "Nada que informar" por valores vendidos en los últimos tres meses. El aviso incluye la declaración estándar de que el vendedor no posee información material adversa no divulgada sobre el emisor.

Artivion, Inc. (AORT)은 제안된 보통주 매각을 보고한 Form 144를 제출했습니다. 제출서에는 10,802주가 08/12/2025Morgan Stanley Smith Barney LLC를 통해 NYSE에서 매각될 예정이며 총 시가가 $471,752.51로 표시되어 있습니다. 발행회사의 유통 주식수는 47,183,658주로 기재되어 있습니다.

해당 증권은 발행회사로부터의 스톡옵션 행사를 통해 08/12/2025에 취득되었으며 현금으로 지급되었습니다. 신고인은 지난 3개월 동안 매각된 증권에 대해 "보고할 사항 없음"이라고 보고했습니다. 통지서에는 매도인이 발행회사에 관한 미공개 중대한 불리한 정보를 보유하고 있지 않다는 표준 진술이 포함되어 있습니다.

Artivion, Inc. (AORT) a déposé un Form 144 signalant une proposition de vente d'actions ordinaires. Le dépôt indique 10,802 actions destinées à la vente le 08/12/2025 par l'intermédiaire de Morgan Stanley Smith Barney LLC sur le NYSE pour une valeur de marché globale de $471,752.51. Le nombre d'actions en circulation de l'émetteur est indiqué comme 47,183,658.

Les titres ont été acquis le 08/12/2025 par exercice d'options sur actions auprès de l'émetteur et réglés en espèces. Le déclarant indique "Rien à déclarer" pour les titres vendus au cours des trois derniers mois. L'avis comprend la déclaration standard selon laquelle le vendeur ne détient pas d'informations défavorables importantes non divulguées concernant l'émetteur.

Artivion, Inc. (AORT) hat ein Form 144 eingereicht, in dem ein geplanter Verkauf von Stammaktien gemeldet wird. Die Einreichung weist 10,802 zum Verkauf vorgesehene Aktien am 08/12/2025 über Morgan Stanley Smith Barney LLC an der NYSE mit einem aggregierten Marktwert von $471,752.51 aus. Die ausstehenden Aktien des Emittenten sind mit 47,183,658 angegeben.

Die Wertpapiere wurden am 08/12/2025 durch Ausübung einer Aktienoption vom Emittenten erworben und in Bargeld bezahlt. Der Einreicher meldet "Nichts zu melden" für in den letzten drei Monaten veräußerte Wertpapiere. Die Mitteilung enthält die übliche Zusicherung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten besitzt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many Artivion (AORT) shares are reported for proposed sale in this Form 144?

The filing reports 10,802 common shares proposed for sale.

What is the aggregate market value of the shares in the AORT Form 144?

The aggregate market value is reported as $471,752.51.

When were the AORT shares acquired and by what method?

The shares were acquired on 08/12/2025 via a stock option exercise from the issuer.

Through which broker and exchange will the AORT shares be sold?

The broker is Morgan Stanley Smith Barney LLC and the sale is listed for the NYSE.

Does the filing report any securities sold in the past three months for the seller?

The filing states "Nothing to Report" for securities sold during the past three months.

How were the shares paid for according to the filing?

Payment for the acquired shares is listed as cash.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.07B
42.07M
5.01%
98.51%
2.89%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW